Biomarin Pharmaceutical Inc
NASDAQ:BMRN

Watchlist Manager
Biomarin Pharmaceutical Inc Logo
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
Watchlist
Price: 60.04 USD 0.15% Market Closed
Market Cap: 11.5B USD

Wall Street
Price Targets

BMRN Price Targets Summary
Biomarin Pharmaceutical Inc

Wall Street analysts forecast BMRN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BMRN is 92.08 USD with a low forecast of 55.55 USD and a high forecast of 128.1 USD.

Lowest
Price Target
55.55 USD
7% Downside
Average
Price Target
92.08 USD
53% Upside
Highest
Price Target
128.1 USD
113% Upside
Biomarin Pharmaceutical Inc Competitors:
Price Targets
HALO
Halozyme Therapeutics Inc
14% Upside
ALNY
Alnylam Pharmaceuticals Inc
25% Upside
OXB
Oxford BioMedica PLC
21% Upside
VLA
Valneva SE
80% Upside
NTLA
Intellia Therapeutics Inc
142% Upside
2256
Abbisko Cayman Ltd
83% Upside
002252
Shanghai RAAS Blood Products Co Ltd
12% Upside
BIIB
Biogen Inc
4% Upside

Revenue
Forecast

Revenue Estimate
Biomarin Pharmaceutical Inc

For the last 13 years the compound annual growth rate for Biomarin Pharmaceutical Inc's revenue is 15%. The projected CAGR for the next 4 years is 8%.

15%
Past Growth
8%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Biomarin Pharmaceutical Inc

The compound annual growth rate of Biomarin Pharmaceutical Inc's operating income for the next 4 years is 22%.

N/A
Past Growth
22%
Estimated Growth
Estimates Accuracy
14%
Average Beat

Net Income
Forecast

Net Income Estimate
Biomarin Pharmaceutical Inc

The compound annual growth rate of Biomarin Pharmaceutical Inc's net income for the next 4 years is 33%.

N/A
Past Growth
33%
Estimated Growth
Estimates Accuracy
-13%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BMRN's stock price target?
Price Target
92.08 USD

According to Wall Street analysts, the average 1-year price target for BMRN is 92.08 USD with a low forecast of 55.55 USD and a high forecast of 128.1 USD.

What is Biomarin Pharmaceutical Inc's Revenue forecast?
Projected CAGR
8%

For the last 13 years the compound annual growth rate for Biomarin Pharmaceutical Inc's revenue is 15%. The projected CAGR for the next 4 years is 8%.

What is Biomarin Pharmaceutical Inc's Operating Income forecast?
Projected CAGR
22%

The compound annual growth rate of Biomarin Pharmaceutical Inc's operating income for the next 4 years is 22%.

What is Biomarin Pharmaceutical Inc's Net Income forecast?
Projected CAGR
33%

The compound annual growth rate of Biomarin Pharmaceutical Inc's net income for the next 4 years is 33%.

Back to Top